HeartFlow
IPODecisive Coronary Care
Public · San Francisco, United States · Founded 2011 · $464.6M raised
- Headquarters
- San Francisco
- Employees
- 501–1000
- Founded
- 2011
- Business Model
- B2B
- Website
- heartflow.com
- Total Funding
- $464.6M
- Last Round
- $98.0M Convertible NoteMar 2025
- Rounds
- 7
- Type
- Public
About
Heartflow is an AI-powered medical technology company empowering clinicians with precision tools to detect, understand, and manage coronary artery disease. Its platform includes FFR CT Analysis, Plaque Analysis, and Roadmap Analysis, enabling personalized cardiac care pathways. Heartflow has treated over 650,000 patients across more than 1,800 institutions with extensive peer-reviewed clinical evidence.
Summary
HeartFlow is a Healthcare company based in San Francisco, United States, founded in 2011. It has raised $464.6M in total across 7 rounds, most recently a $98.0M Convertible Note round in Mar 2025. Investors include Bain Capital Life Sciences, Andreessen Horowitz and GV.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2025
Sign up to see all 8 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe


